Esophageal cancer: Risk factors, screening and endoscopic treatment in Western and Eastern countries

World Journal of Gastroenterology

Volumn 21, Issue 26, 2015, Pages 7933-7943

  Arnal, María José Domper ^a   Arenas, Ángel Ferrández ^a   Arbeloa, Ángel Lanas ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

Author keywords

Adenocarcinoma; Barrett's oesophagus; Early stage; Endoscopic mucosal resection; Endoscopic submucosal disection; Epidemiology; Oesophageal cancer; Screening; Squamous cell carcinoma

Indexed keywords

ALCOHOL;

ALCOHOL CONSUMPTION; BARRETT ESOPHAGUS; CANCER EPIDEMIOLOGY; CANCER GENETICS; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; CANCER STAGING; COST EFFECTIVENESS ANALYSIS; DIET; EARLY CANCER; EARLY DIAGNOSIS; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGOSCOPY; ESOPHAGUS CANCER; ESOPHAGUS CARCINOMA; GASTROESOPHAGEAL REFLUX; HUMAN; NUTRIENT; NUTRITIONAL DEFICIENCY; OBESITY; RACE DIFFERENCE; REVIEW; SEX DIFFERENCE; SMOKING; SURVIVAL RATE; TOBACCO; ADENOCARCINOMA; ANCESTRY GROUP; CARCINOMA, SQUAMOUS CELL; EARLY CANCER DIAGNOSIS; ESOPHAGEAL NEOPLASMS; ESOPHAGUS RESECTION; ETHNOLOGY; INCIDENCE; MORTALITY; PATHOLOGY; PREDICTIVE VALUE; PROCEDURES; RISK FACTOR; TREATMENT OUTCOME;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; CONTINENTAL POPULATION GROUPS; EARLY DETECTION OF CANCER; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; ESOPHAGOSCOPY; HUMANS; INCIDENCE; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; RISK FACTORS; TREATMENT OUTCOME;

EID: 84937022269     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i26.7933     Document Type: Review

References (37)

1. Pennathur A, Gibson MK, Jobe BA, Luketich JD. Oesophageal carcinoma. Lancet 2013; 381: 400-412 [PMID: 23374478 DOI: 10.1016/S0140-6736(12)60643-6]
2. Zhang Y. Epidemiology of esophageal cancer. World J Gastroenterol 2013; 19: 5598-5606 [PMID: 24039351 DOI: 10.3748/wjg.v19.i34.5598]
3. Zhang HZ, Jin GF, Shen HB. Epidemiologic differences in esophageal cancer between Asian and Western populations. Chin J Cancer 2012; 31: 281-286 [PMID: 22507220 DOI: 10.5732/cjc.011.10390]
4. Wheeler JB, Reed CE. Epidemiology of esophageal cancer. Surg Clin North Am 2012; 92: 1077-1087 [PMID: 23026270 DOI: 10.1016/j.suc.2012.07.008]
5. International agency for research on cancer. Available from: URL: http://globocan.iarc.fr/Default.aspx
6. Yang X, Zhu H, Qin Q, Yang Y, Yang Y, Cheng H, Sun X. Genetic variants and risk of esophageal squamous cell carcinoma: a GWAS-based pathway analysis. Gene 2015; 556: 149-152 [PMID: 25431829 DOI: 10.1016/j.gene.2014.11.049]
7. Alcedo J, Ferrández A, Arenas J, Sopeña F, Ortego J, Sainz R, Lanas A. Trends in Barrett's esophagus diagnosis in Southern Europe: implications for surveillance. Dis Esophagus 2009; 22: 239-248 [PMID: 19425201 DOI: 10.1111/j.1442-2050.2008.00908. x]
8. Hvid-Jensen F, Pedersen L, Drewes AM, Sørensen HT, Funch-Jensen P. Incidence of adenocarcinoma among patients with Barrett's esophagus. N Engl J Med 2011; 365: 1375-1383 [PMID: 21995385 DOI: 10.1056/NEJMoa1103042]
9. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008; 371: 569-578 [PMID: 18280327 DOI: 10.1016/S0140-6736(08)60269-X]
10. Kubo A, Corley DA. Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 2006; 15: 872-878 [PMID: 16702363 DOI: 10.1158/1055-9965.EPI-05-0860]
11. Oze I, Matsuo K, Ito H, Wakai K, Nagata C, Mizoue T, Tanaka K, Tsuji I, Tamakoshi A, Sasazuki S, Inoue M, Tsugane S. Cigarette smoking and esophageal cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol 2012; 42: 63-73 [PMID: 22131340 DOI: 10.1093/jjco/hyr170]
12. Singh S, Garg SK, Singh PP, Iyer PG, El-Serag HB. Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett's oesophagus: a systematic review and meta-analysis. Gut 2014; 63: 1229-1237 [PMID: 24221456 DOI: 10.1136/gutjnl-2013-305997]
13. Hvid-Jensen F, Pedersen L, Funch-Jensen P, Drewes AM. Proton pump inhibitor use may not prevent high-grade dysplasia and oesophageal adenocarcinoma in Barrett's oesophagus: a nationwide study of 9883 patients. Aliment Pharmacol Ther 2014; 39: 984-991 [PMID: 24617286 DOI: 10.1111/apt.12693]
14. Ek WE, Levine DM, D'Amato M, Pedersen NL, Magnusson PK, Bresso F, Onstad LE, Schmidt PT, Törnblom H, Nordenstedt H, Romero Y, Chow WH, Murray LJ, Gammon MD, Liu G, Bernstein L, Casson AG, Risch HA, Shaheen NJ, Bird NC, Reid BJ, Corley DA, Hardie LJ, Ye W, Wu AH, Zucchelli M, Spector TD, Hysi P, Vaughan TL, Whiteman DC, MacGregor S. Germline genetic contributions to risk for esophageal adenocarcinoma, Barrett's esophagus, and gastroesophageal refux. J Natl Cancer Inst 2013; 105: 1711-1718 [PMID: 24168968 DOI: 10.1093/jnci/djt303]
15. Levine DM, Ek WE, Zhang R, Liu X, Onstad L, Sather C, Lao-Sirieix P, Gammon MD, Corley DA, Shaheen NJ, Bird NC, Hardie LJ, Murray LJ, Reid BJ, Chow WH, Risch HA, Nyrén O, Ye W, Liu G, Romero Y, Bernstein L, Wu AH, Casson AG, Chanock SJ, Harrington P, Caldas I, Debiram-Beecham I, Caldas C, Hayward NK, Pharoah PD, Fitzgerald RC, Macgregor S, Whiteman DC, Vaughan TL. A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett' s esophagus. Nat Genet 2013; 45: 1487-1493 [PMID: 24121790 DOI: 10.1038/ng.2796]
16. Lao-Sirieix P, Fitzgerald RC. Screening for oesophageal cancer. Nat Rev Clin Oncol 2012; 9: 278-287 [PMID: 22430857]
17. Fernández G, Baiges A, Visa L, Castelles A. Cáncer de esófago. España: CTO editorial
18. Rustgi AK, El-Serag HB. Esophageal carcinoma. N Engl J Med 2014; 371: 2499-2509 [PMID: 25539106 DOI: 10.1056/NEJMra1314530]
19. Spechler SJ, Souza RF. Barrett's esophagus. N Engl J Med 2014; 371: 836-845 [PMID: 25162890 DOI: 10.1056/NEJMra1314704]
20. Garside R, Pitt M, Somerville M, Stein K, Price A, Gilbert N. Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling. Health Technol Assess 2006; 10: 1-142, iii-iv [PMID: 16545207 DOI: 10.3310/hta10080]
21. Gordon LG, Mayne GC, Hirst NG, Bright T, Whiteman DC, Watson DI. Cost-effectiveness of endoscopic surveillance of non-dysplastic Barrett's esophagus. Gastrointest Endosc 2014; 79: 242-56.e6 [PMID: 24079411 DOI: 10.1016/j.gie.2013.07.046]
22. Hirst NG, Gordon LG, Whiteman DC, Watson DI, Barendregt JJ. Is endoscopic surveillance for non-dysplastic Barrett's esophagus cost-effective? Review of economic evaluations. J Gastroenterol Hepatol 2011; 26: 247-254 [PMID: 21261712 DOI: 10.1111/j.1440-1746.2010.06506.x]
23. Lin Y, Totsuka Y, He Y, Kikuchi S, Qiao Y, Ueda J, Wei W, Inoue M, Tanaka H. Epidemiology of esophageal cancer in Japan and China. J Epidemiol 2013; 23: 233-242 [PMID: 23629646 DOI: 10.2188/jea.JE20120162]
24. Wang GQ, Abnet CC, Shen Q, Lewin KJ, Sun XD, Roth MJ, Qiao YL, Mark SD, Dong ZW, Taylor PR, Dawsey SM. Histological precursors of oesophageal squamous cell carcinoma: results from a 13 year prospective follow up study in a high risk population. Gut 2005; 54: 187-192 [PMID: 15647178 DOI: 10.1136/gut.2004.046631]
25. Lu YF, Liu ZC, Li ZH, Ma WH, Wang FR, Zhang YB, Lu JB. Esophageal/gastric cancer screening in high-risk populations in Henan Province, China. Asian Pac J Cancer Prev 2014; 15: 1419-1422 [PMID: 24606476 DOI: 10.7314/APJCP.2014.15.3.1419]
26. Yang J, Wei WQ, Niu J, Liu ZC, Yang CX, Qiao YL. Cost-beneft analysis of esophageal cancer endoscopic screening in high-risk areas of China. World J Gastroenterol 2012; 18: 2493-2501 [PMID: 22654446 DOI: 10.3748/wjg.v18.i20.2493]
27. Yang J, Wei WQ, Niu J, He YT, Liu ZC, Song GH, Zhao de L, Qiao YL, Yang CX. Estimating the costs of esophageal cancer screening, early diagnosis and treatment in three high risk areas in China. Asian Pac J Cancer Prev 2011; 12: 1245-1250 [PMID: 21875275]
28. Roshandel G, Nourouzi A, Pourshams A, Semnani S, Merat S, Khoshnia M. Endoscopic screening for esophageal squamous cell carcinoma. Arch Iran Med 2013; 16: 351-357 [PMID: 23725069]
29. Ponce J, Castells T, Gomollón F, Esteve M, Martín de Argila C, Molero X, Vázquez Sequeiros E, editors. Treatment of gastroenterological diseases. 3rd ed. Madrid: Elsevier, 2011: 155-156
30. Westerterp M, Koppert LB, Buskens CJ, Tilanus HW, ten Kate FJ, Bergman JJ, Siersema PD, van Dekken H, van Lanschot JJ. Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastro-esophageal junction. Virchows Arch 2005; 446: 497-504 [PMID: 15838647 DOI: 10.1007/s00428-005-1243-1]
31. Lin JL. T1 esophageal cancer, request an endoscopic mucosal resection (EMR) for in-depth review. J Thorac Dis 2013; 5: 353-356 [PMID: 23825773]
32. Gockel I, Sgourakis G, Lyros O, Polotzek U, Schimanski CC, Lang H, Hoppo T, Jobe BA. Risk of lymph node metastasis in submucosal esophageal cancer: a review of surgically resected patients. Expert Rev Gastroenterol Hepatol 2011; 5: 371-384 [PMID: 21651355 DOI: 10.1586/egh.11.33]
33. Pech O, Behrens A, May A, Nachbar L, Gossner L, Rabenstein T, Manner H, Guenter E, Huijsmans J, Vieth M, Stolte M, Ell C. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett' s oesophagus. Gut 2008; 57: 1200-1206 [PMID: 18460553 DOI: 10.1136/gut.2007.142539]
34. Wani S, Drahos J, Cook MB, Rastogi A, Bansal A, Yen R, Sharma P, Das A. Comparison of endoscopic therapies and surgical resection in patients with early esophageal cancer: a population-based study. Gastrointest Endosc 2014; 79: 224-232.e1 [PMID: 24060519 DOI: 10.1016/j.gie.2013.08.002]
35. Hammad H, Kaltenbach T, Soetikno R. Endoscopic submucosal dissection for malignant esophageal lesions. Curr Gastroenterol Rep 2014; 16: 386 [PMID: 24659252 DOI: 10.1007/s11894-014-0386-0]
36. Wang J, Ge J, Zhang XH, Liu J Y, Yang CM, Zhao SL. Endoscopic submucosal dissection versus endoscopic mucosal resection for the treatment of early esophageal carcinoma: a meta-analysis. Asian Pac J Cancer Prev 2014; 15: 1803-1806 [PMID: 24641412 DOI: 10.7314/APJCP.2014.15.4.1803]
37. Sun F, Yuan P, Chen T, Hu J. Efficacy and complication of endoscopic submucosal dissection for superficial esophageal carcinoma: a systematic review and meta-analysis. J Cardiothorac Surg 2014; 9: 78 [PMID: 24885614 DOI: 10.1186/1749-8090-9-78]